Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Meridian Bioscience Inc. market cap is $1.49B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Meridian Bioscience Inc. 52 week high is $34.38 as of September 27, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Meridian Bioscience Inc. 52 week low is $21.09 as of September 27, 2023.
Meridian Bioscience Inc. stock price today is $33.98.
Meridian Bioscience Inc. stock price yesterday was $33.97.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Meridian Bioscience Inc.’s P/E ratio is 35.49.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Meridian Bioscience Inc. P/B ratio is 4.0375.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Meridian Bioscience Inc.'s EBITDA is 18.22.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Meridian Bioscience Inc. 50-day moving average is $32.94.
Meridian Bioscience Inc. has 515 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.